TMAM
HZNP

Tokio Marine Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Tokio Marine Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-71,300
Closed -$8.25M – 577
2023
Q3 		$8.25M Sell
71,300
-35,100
-33% -$3.77M 0.52% 49
2023
Q2 		$10.9M Sell
106,400
-76,700
-42% -$8.09M 0.7% 36
2023
Q1 		$20M Buy
183,100
+129,476
+241% +$14.3M 1.39% 12
2022
Q4 		$6.1M Buy
+53,624
New +$4.45M 0.48% 48

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Tokio Marine Asset Management's HZNP Position: Q4 2023 in Review

Tokio Marine Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 71,300 shares — an estimated $8.25M sold.

Tokio Marine Asset Management first reported a position in HZNP in Q4 2022 and held it in 4 quarters. The position peaked at $20M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Tokio Marine Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Tokio Marine Asset Management sold 71,300 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $8.25M.
  • Tokio Marine Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022 and held it in 4 quarters.
  • Tokio Marine Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $20M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Tokio Marine Asset Management's 13F filing for Q4 2023, filed 2 Feb 2024.